Back to CAPTRUST FINANCIAL ADVISORS CAPTRUST FINANCIAL ADVISORS

NKTRNKTR

Showing 4 of 22 quarters

Position history for CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS's holdings in Nektar Therapeutics

Final Value

$0

Final Shares

0

Total Value Change

-$16,572

Total Shares Change

-12,748

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$25.76
0
2025-Q1
Increased
32,152
+167.9%
$21,8630.0%$11.10
30
2024-Q4
Decreased
12,001
-5.9%
$11,1610.0%$14.10
0
2024-Q3
Increased
12,748
+6.2%
$16,5720.0%$17.55
13

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used